Use of reverse dot blot hybridization DNA-array and targeted next-generation sequencing for the detection of drug resistance in patients with tuberculosis: a prospective diagnostic accuracy study
European Journal of Clinical Microbiology & Infectious Diseases · 2026-06 · 45 (6) · 1707-1720
DOI: 10.1007/s10096-026-05451-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Clinical Microbiology & Infectious Diseases, online erschienen am 06.03.2026. Verfasst von Andrii Dudnyk und 10 weiteren Autor:innen. Beteiligte Einrichtung: Germans Trias i Pujol Research Institute (IGTP), Badalona, Barcelona, Spain. andriidudnyk@vnmu.edu.ua. Die Arbeit nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: MSCA4Ukraine project, European Union's Horizon 2020 Research and Innovation Programme under the Marie Skłodowska-Curie grant agreement, European Cooperation Science and Technology.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Germans Trias i Pujol Research Institute (IGTP), Badalona, Barcelona, Spain. andriidudnyk@vnmu.edu.ua.
- Department of Tuberculosis, Clinical Immunology and Allergy, National Pirogov Memorial Medical University, Vinnytsia, Ukraine. andriidudnyk@vnmu.edu.ua.
- Serveis Clinics, Barcelona, Spain. andriidudnyk@vnmu.edu.ua.
- Serveis Clínics, García Mariño Street, 4, Barcelona, 08022, Spain. andriidudnyk@vnmu.edu.ua.
- Germans Trias i Pujol Research Institute (IGTP), Badalona, Barcelona, Spain.
- Odesa I. I. Mechnikov National University, Odesa, Ukraine.
Förderung
- MSCA4Ukraine project
- European Union's Horizon 2020 Research and Innovation Programme under the Marie Skłodowska-Curie grant agreement
- European Cooperation Science and Technology
- Instituto de Salud Carlos III
- European Union’s Horizon 2020 Research and Innovation Programme under the Marie Skłodowska-Curie grant agreement
Zitieren
APA
Dudnyk, A., Tytarenko, N., Andrada, I. R., Lytvyniuk, O., Tolstova, O., Millet, J. P., Casas, X., Antuori, A., Ciobanu, N., Crudu, V., & Domínguez, J. (2026). Use of reverse dot blot hybridization DNA-array and targeted next-generation sequencing for the detection of drug resistance in patients with tuberculosis: a prospective diagnostic accuracy study. European Journal of Clinical Microbiology & Infectious Diseases, 45(6), 1707-1720. https://doi.org/10.1007/s10096-026-05451-2
Vancouver
Dudnyk A, Tytarenko N, Andrada IR, Lytvyniuk O, Tolstova O, Millet JP, et al. Use of reverse dot blot hybridization DNA-array and targeted next-generation sequencing for the detection of drug resistance in patients with tuberculosis: a prospective diagnostic accuracy study. European Journal of Clinical Microbiology & Infectious Diseases. 2026;45(6):1707-1720. doi:10.1007/s10096-026-05451-2
BibTeX
@article{Dudnyk2026,
author = {Dudnyk, Andrii and Tytarenko, Nadiia and Andrada, Iris Romero and Lytvyniuk, Oksana and Tolstova, Olena and Millet, Joan-Pau and Casas, Xavier and Antuori, Adrian and Ciobanu, Nelly and Crudu, Valeriu and Domínguez, José},
title = {Use of reverse dot blot hybridization DNA-array and targeted next-generation sequencing for the detection of drug resistance in patients with tuberculosis: a prospective diagnostic accuracy study},
journal = {European Journal of Clinical Microbiology & Infectious Diseases},
year = {2026},
volume = {45},
number = {6},
pages = {1707--1720},
doi = {10.1007/s10096-026-05451-2}
}
EUVIMED